Imagion Biosystems Ltd has released a press release.
Imagion Funding Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
In the deck
Story so far
Earlier from Imagion Biosystems
- Non-renounceable Entitlement Offer
- Imagion Secures Growth Funding
- Appendix 4E
- Company Update - Phase 1 Study Independent Review
- Positive clinical data reported at breast cancer symposium
Later from Imagion Biosystems
- Results of Non-renounceable Entitlement Offer
- Imagion Announces New CEO
- Imagion to complete the MagSense HER2 Phase 1 Study
- Non-renounceable Entitlement Offer Shortfall
- Half-Year Results Release
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems